Atara Biotherapeutics Inc. (NASDAQ: ATRA)
$11.30
+0.8250 ( +7.88% ) 44.1K
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
Market Data
Open
$11.30
Previous close
$10.47
Volume
44.1K
Market cap
$54.73M
Day range
$9.85 - $11.59
52 week range
$4.97 - $63.38
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 22 | Apr 26, 2024 |
pre | Proxies and info statements | 22 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
8-k | 8K-related | 11 | Mar 29, 2024 |
8-k | 8K-related | 12 | Mar 28, 2024 |
10-k | Annual reports | 96 | Mar 28, 2024 |